“showed a trend”

In univariate analysis, elevated baseline LDH showed a trend toward shorter PFS (HR, 2.08; 95% CI, 0.86-5.00; p = 0.103).

Neutrophilia showed a trend toward decreased mortality risk (aHR, 0.44; 95% CI, 0.17–1.18; p = 0.103) in this model.

Target attainment showed a trend toward higher total ICU costs (€44,600 versus €28,200, P = 0.103).

The high-dose-treated mice showed a trend of less GFAP accumulation in the brain compared to mock-treated mice ( p = 0.103 by a 2 sample t -test on the logarithms of the levels), whereas no difference was detected between the low-dose-treated and mock infected mice ( p = 0.906 again by a 2 sample t -test) as seen in Fig 2 .

Hepatitis B or C coinfection showed a trend toward increased discordance (aOR 2.94, P = .103), possibly due to immune dysregulation, as reported in a TB-HCV coinfection study [ 36 ].

Caregiver age showed a trend-level effect (Wilks’ λ = 0.834, F(6,56) = 1.86, p = 0.1032).

2 B, p = 0.0024) and spermidine supplementation in GWI mice, although not significant, showed a trend toward increased branching compared to GWI mice ( p = 0.1035).

T1Gd good responders showed a trend toward longer PFS (p = 0.1037), while T2/FLAIR poor responders also showed a similar trend (p = 0.0688).

Autoimmune Mechanism In our study, a history of autoimmune disease showed a trend toward an increased risk of recurrence (HR = 2.99, p = 0.104), although this did not reach statistical significance.

In the 8.5 mut/Mb model, only PD-L1 expression ≥ 1% was significantly associated with longer PFS (HR: 0.41; 95% CI: 0.22–0.76; p = 0.002), while STK11 / KEAP1 / NFE2L2 mutations showed a trend toward shorter PFS (HR: 1.58; 95% CI: 0.78–3.24; p = 0.104; Figure 5A ).

Although not reaching statistical significance, group 1 patients showed a trend toward having more genetic alterations in the RTK/RAS and PI3K pathways ( p = 0.104 and p = 0.611, respectively), while those in group 2 were more likely to carry TP53 mutations and alterations in the HIPPO pathway ( p = 0.184 and p = 0.659, respectively) (Figure 3I ).

In terms of the time to MB or CRB, rivaroxaban showed a trend of being a risk factor for MB (HR 3.89; p = 0.104) and CRB (HR 2.37; p = 0.102) compared to dalteparin ( Table S2 ).

While not significant, Class 2 showed a trend towards better CA‐125 response ( p = .104, Figure 3E ). 3.6.

Salem et al[ 99 ] showed a trend towards a higher response rate for patients who underwent TARE as compared to TACE (49% vs 36%, respectively, P = 0.104).

However, in multivariable Cox regression models adjusted for TNM stage and history of breast disease, the GATA6high/TGFB2-AS1low signature did not reach statistical significance as an independent prognostic factor—though it showed a trend toward worse DFS (HR = 1.86, 95% CI: 0.88–3.93; P = 0.104) and no significant association with OS (HR = 1.15, 95% CI: 0.39–3.37; P = 0.799).

Four out of ninety-nine lncRNAs, namely NRIR, PSMB8-AS1, RP5-1091N2.9, and RP11-24F11.2, were expressed at significantly higher levels in at least two groups of SSc patients as compared to their respective healthy donors in the “definite SSc” cohort ( Figure 3A ), whereas only NRIR was significantly up-regulated in ncSSc and showed a trend in eaSSc (FC = 1.30, p = 0.104) in the “non-fibrotic” cohort ( Figure 3B ).

The infected HFD mice showed a trend of relatively higher generation of NETs in their lungs at 6 DPI ( P = 0.104) and 10 DPI ( P = 0.111) (Figures 4 C,D).

MDR status showed a trend towards higher concordance (OR = 1.52, p = 0.104), suggesting that physicians are more likely to follow CDSS recommendations when dealing with multidrug-resistant infections.

An increase in plasma tRF-TyrGTA1–19 levels in IS patients showed a trend toward higher expression compared with ICH patients ( p = 0.1041).

WT) and showed a trend toward increase on day 3 ( p = 0.1044 vs.

3D ), while the expression level of Na v 1.6 showed a trend of reduction ( P = 0.105).

3.6.3 Profilometric Measurements At region of interest 1 (ROI‐1), profilometric contour changes did not differ significantly among the three groups ( p = 0.346), although all groups showed a trend towards slight loss of contour over time ( p = 0.105) (Table 5 ).

In metastatic gastric cancer, TWIST-positive circulating tumor cells (CTCs) were detected in 77.4% of patients, and counts exceeding 2.5 per 7.5 mL blood showed a trend toward reduced survival (p = 0.105) ( Jhi et al., 2021 ).

The absence of calcification showed a trend toward greater VAS improvement (β = −0.43; p = 0.105).

There was no group effect following intervention in an ancova model considering positive and negative vigilance simultaneously, however, simple effects contrasts of group responses to negative and positive vigilance separately showed a trend towards a reduction in negative vigilance following intervention in the GOS group compared to placebo group (β -30.75 ms, SE = 18.58, p =.105), Fig. 3 B.